Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
NanoCarrier Co
company
About
NanoCarrier Co is a pharmaceutical company that researches and develops medical products by applying the micellar nanoparticle technology.
- 11 - 50
Details
- Last Funding Type
- Corporate Round
- Last Funding Money Raised
- ¥399M
- Industries
- Biotechnology,Nanotechnology,Pharmaceutical
- Founded date
- Jan 1, 1996
- Number Of Employee
- 11 - 50
- Operating Status
- Active
NanoCarrier Co is a pharmaceutical company that researches and develops medical products by applying the micellar nanoparticle technology. The company was founded on June 14, 1996, and is headquartered in Chiba, Japan with presence in Tokyo.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥2.12B
NanoCarrier Co has raised a total of
¥2.12B
in funding over 2 rounds. Their latest funding was raised on
Mar 20, 2006 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 20, 2006 | Corporate Round | ¥399M | 1 | — | — | Detail |
| Jan 31, 2004 | Series Unknown | ¥1.72B | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
NanoCarrier Co is funded by 2 investors.
Nomura Research and Advisory
and Fulcrum Pharma Developments
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series Unknown |
Fulcrum Pharma Developments
|
— | Corporate Round |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
